Advertisement
Canada markets closed
  • S&P/TSX

    21,642.87
    -97.33 (-0.45%)
     
  • S&P 500

    5,051.41
    -10.41 (-0.21%)
     
  • DOW

    37,798.97
    +63.86 (+0.17%)
     
  • CAD/USD

    0.7235
    +0.0002 (+0.03%)
     
  • CRUDE OIL

    85.29
    -0.07 (-0.08%)
     
  • Bitcoin CAD

    88,175.24
    +434.69 (+0.50%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,400.70
    -7.10 (-0.29%)
     
  • RUSSELL 2000

    1,967.48
    -8.23 (-0.42%)
     
  • 10-Yr Bond

    4.6590
    +0.0310 (+0.67%)
     
  • NASDAQ futures

    17,910.00
    +28.75 (+0.16%)
     
  • VOLATILITY

    18.40
    -0.83 (-4.32%)
     
  • FTSE

    7,820.36
    -145.17 (-1.82%)
     
  • NIKKEI 225

    38,471.20
    -761.60 (-1.94%)
     
  • CAD/EUR

    0.6810
    -0.0014 (-0.21%)
     

Announcing: LeoNovus (CVE:LTV) Stock Increased An Energizing 186% In The Last Three Years

Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card!

LeoNovus Inc. (CVE:LTV) shareholders might understandably be very concerned that the share price has dropped 31% in the last quarter. But that doesn't change the fact that the returns over the last three years have been very strong. In fact, the share price is up a full 186% compared to three years ago. After a run like that some may not be surprised to see prices moderate. The fundamental business performance will ultimately dictate whether the top is in, or if this is a stellar buying opportunity.

View our latest analysis for LeoNovus

ADVERTISEMENT

We don't think LeoNovus's revenue of US$14,000 is enough to establish significant demand. As a result, we think it's unlikely shareholders are paying much attention to current revenue, but rather speculating on growth in the years to come. Investors will be hoping that LeoNovus can make progress and gain better traction for the business, before it runs low on cash.

Companies that lack both meaningful revenue and profits are usually considered high risk. There is usually a significant chance that they will need more money for business development, putting them at the mercy of capital markets. So the share price itself impacts the value of the shares (as it determines the cost of capital). While some such companies go on to make revenue, profits, and generate value, others get hyped up by hopeful naifs before eventually going bankrupt. Some LeoNovus investors have already had a taste of the sweet taste stocks like this can leave in the mouth, as they gain popularity and attract speculative capital.

LeoNovus had net cash of just US$2.4m when it last reported (December 2018). So if it has not already moved to replenish reserves, we think the near-term chances of a capital raising event are pretty high. Given how low on cash the it got, investors must really like its potential for the share price to be up 42% per year, over 3 years. You can click on the image below to see (in greater detail) how LeoNovus's cash levels have changed over time.

TSXV:LTV Historical Debt, May 7th 2019
TSXV:LTV Historical Debt, May 7th 2019

In reality it's hard to have much certainty when valuing a business that has neither revenue or profit. Given that situation, many of the best investors like to check if insiders have been buying shares. It's usually a positive if they have, as it may indicate they see value in the stock. You can click here to see if there are insiders buying.

A Different Perspective

Investors in LeoNovus had a tough year, with a total loss of 31%, against a market gain of about 4.6%. However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. Unfortunately, last year's performance may indicate unresolved challenges, given that it was worse than the annualised loss of 25% over the last half decade. Generally speaking long term share price weakness can be a bad sign, though contrarian investors might want to research the stock in hope of a turnaround. Most investors take the time to check the data on insider transactions. You can click here to see if insiders have been buying or selling.

But note: LeoNovus may not be the best stock to buy. So take a peek at this free list of interesting companies with past earnings growth (and further growth forecast).

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on CA exchanges.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.